Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Oncology ; 101(9): 565-574, 2023.
Article in English | MEDLINE | ID: mdl-37276856

ABSTRACT

INTRODUCTION: Atezolizumab plus bevacizumab (ATZ+BV) treatment has become the first-line regimen for unresectable hepatocellular carcinoma (u-HCC). Prediction of response to it might be clinically beneficial. Using peripheral blood parameters, we aimed to construct a prediction model for ATZ+BV treatment. METHODS: Clinical records of 119 patients with u-HCC treated by ATZ+BV were retrospectively analyzed. The primary outcome measurement was defined as any-size reduction at the initial image evaluation. Using baseline values of peripheral blood parameters, a prediction model was constructed by univariate and multivariate logistic regression analysis. Validation was performed internally by bootstrap method. RESULTS: The primary outcome was achieved in 46 patients. Univariate analysis showed that C-reactive protein (CRP), alpha-fetoprotein (AFP), des-gamma-carboxy prothrombin (DCP), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) were possible predictors. CRP and DCP, and NLR and PLR had correlation (correlation coefficient >0.3), so we used CRP and NLR as representative factors, respectively. Multivariate analysis constructed the following prediction model: Logit = 1.62-0.61×[CRP] -0.38×[Log10AFP] -0.37×[NLR]. Bootstrapped median (95% confidence interval) of coefficients of CRP, Log10AFP, NLR were -0.64 (-1.46 ∼ -0.11), -0.40 (-0.82 ∼ -0.03), and -0.38 (-0.74 ∼ -0.05), respectively. The area under the receiver operating characteristic curve (95% confidence interval) was 0.73 (0.60-0.80). Median overall survival of the favorably and unfavorably predicted groups were 17.0 and 11.0 months (p = 0.03), respectively. DISCUSSION: In patients with u-HCC treated by ATZ+BEV, a prediction model constructed using baseline values of CRP, AFP, and NLR had impact on any-size reduction at the initial image evaluation and on prognosis.


Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , Humans , Carcinoma, Hepatocellular/pathology , alpha-Fetoproteins/metabolism , Retrospective Studies , Bevacizumab , Liver Neoplasms/pathology , Prognosis , C-Reactive Protein/metabolism
2.
Front Public Health ; 10: 881303, 2022.
Article in English | MEDLINE | ID: mdl-35910937

ABSTRACT

Background: School refusal occurs in about 1-2% of young people. Anxiety and depression are considered to be the most common emotional difficulties for children who do not attend school. However, at present, no definitive treatment has been established for school refusal, although interventions such as cognitive behavioral therapy have been used. This paper reports a protocol for a cluster-randomized controlled trial of a mindfulness yoga intervention for children with school refusal. Methods: This study is a multicenter, exploratory, open cluster-randomized controlled trial. This study will recruit children aged 10-15 years with school refusal. After a 2-week baseline, participants for each cluster will be randomly assigned to one of two groups: with or without mindfulness yoga for 4 weeks. Mindfulness yoga will be created for schoolchildren for this protocol and distributed to the participants on DVD. The primary outcome is anxiety among children with school refusal using the Spence Children's Anxiety Scale-Children. Discussion: For this study, we developed a mindfulness yoga program and protocol, and examine whether mindfulness yoga can improve anxiety in children with school refusal. Our mindfulness yoga program was developed based on the opinions of children of the same age, and is a program that children can continue to do every day without getting bored. In this way, we believe that we can contribute to the smooth implementation of support to reduce the anxiety of children with school refusal, and to the reduction of the number of children who refuse to go to school.


Subject(s)
Mindfulness , Yoga , Adolescent , Anxiety/therapy , Child , Humans , Mindfulness/methods , Multicenter Studies as Topic , Randomized Controlled Trials as Topic , Schools , Yoga/psychology
3.
Eur J Neurosci ; 24(11): 2993-3007, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17156361

ABSTRACT

The rocker mice are hereditary ataxic mutants that carry a point mutation in the gene encoding the CaV2.1 (P/Q-type) Ca2+ channel alpha1 subunit, and show the mildest symptoms among the reported CaV2.1 mutant mice. We studied the basic characteristics of the rocker mutant Ca2+ channel and their impacts on excitatory synaptic transmission in cerebellar Purkinje cells (PCs). In acutely dissociated PC somas, the rocker mutant channel showed a moderate reduction in Ca2+ channel current density, whereas its kinetics and voltage dependency of gating remained nearly normal. Despite the small changes in channel function, synaptic transmission in the parallel fiber (PF)-PC synapses was severely impaired. The climbing fiber inputs onto PCs showed a moderate impairment but could elicit normal complex spikes. Presynaptic function of the PF-PC synapses, however, was unexpectedly almost normal in terms of paired-pulse facilitation, sensitivity to extracellular Ca2+ concentration and glutamate concentration in synaptic clefts. Electron microscopic analyses including freeze-fracture replica labeling revealed that both the number and density of postsynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors substantially decreased without gross structural changes of the PF-PC synapses. We also observed an abnormal arborization of PC dendrites in young adult rocker mice (approximately 1 month old). These lines of evidence suggest that even a moderate dysfunction of CaV2.1 Ca2+ channel can cause substantial changes in postsynaptic molecular composition of the PF-PC synapses and dendritic structure of PCs.


Subject(s)
Calcium Channels, N-Type/genetics , Cerebellar Cortex/metabolism , Mutation/genetics , Purkinje Cells/metabolism , Receptors, AMPA/metabolism , Synapses/metabolism , Action Potentials/genetics , Animals , Calcium/metabolism , Cell Differentiation/genetics , Cerebellar Cortex/pathology , Cerebellar Cortex/physiopathology , Cerebellar Diseases/genetics , Cerebellar Diseases/metabolism , Cerebellar Diseases/physiopathology , Dendrites/metabolism , Dendrites/pathology , Down-Regulation/genetics , Female , Glutamic Acid/metabolism , Ion Channel Gating/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Neurologic Mutants , Patch-Clamp Techniques , Purkinje Cells/pathology , Synaptic Membranes/genetics , Synaptic Membranes/metabolism , Synaptic Membranes/pathology , Synaptic Transmission/genetics
4.
Drug Metab Pharmacokinet ; 20(2): 113-6, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15855722

ABSTRACT

The -1584C/G single nucleotide polymorphism (SNP) in the promoter region of CYP2D6 was suggested to have the potential to influence CYP2D6 activity. In this report, we demonstrated the frequencies of -1584C to G substitution-related alleles, such as CYP2D6*2, CYP2D6*21, CYP2D6*35 and CYP2D6*41, in the Japanese population. The frequencies of CYP2D6*2, *41 and *21 were 0.102, 0.026 and 0.005, respectively. We also showed a relationship between the SNP and other common alleles, CYP2D6*4, *5, *10, *14 and *18. Interestingly, the SNP was detected in all three subjects carrying CYP2D6*14. This finding suggests the -1584G is included in the CYP2D6*14 allele, which is a null-allele characteristic to the Japanese population. This report presents practical information on CYP2D6 alleles that should be considered in the pharmacokinetic study of CYP2D6 substrates in the Japanese population.


Subject(s)
Asian People , Cysteine/genetics , Cytochrome P-450 CYP2D6/genetics , Glycine/genetics , Alleles , Amino Acid Substitution , Genotype , Humans , Male
5.
J Occup Health ; 45(1): 15-22, 2003 Jan.
Article in English | MEDLINE | ID: mdl-14605424

ABSTRACT

To understand how psychological characteristics influence adoption and maintenance of physical activity/exercise, we conducted a cross-sectional study among Japanese employees based upon the idea of stages of behavior modification. The study population consisted of 719 employees (male, 396, female, 323) from five medium-sized manufacturing companies (50-200 employees) in Okayama Prefecture, Japan. The female response rate was 67.5% (n=218), among which 201 eligible female subjects (62.2%) were analyzed. The study questionnaire included demographic characteristics, physical activity/exercise measures, self-efficacy measures, and perceived benefit and barriers scales. Participants were asked to select the items that best described their current physical activity/exercise level from an 8-item questionnaire, and we converted their answers to the 5 stages of change according to a transtheoretical model of behavior change. Perceived benefit and barrier scales were classified into 7 factors (4 benefits and 3 barriers) by factor analyses. The relationship between psychological determinants and the stage of physical activity/exercise was examined by one-way analysis of variance. Only 10% of the subjects had moderate physical activity (in the action and maintenance stages) regularly. We found that self-efficacy, "weight control benefit", "physical barrier" and "time barrier" were psychological determinants of physical activity/exercise stages in female employees, and especially there was a consistent relationship between self-efficacy and the stage of physical activity/exercise. Our data suggest that health education for Japanese female employees requires that health professionals should provide support for strengthening self-efficacy, show practical ways to increase physical activity in daily life, and provide broad and accurate information showing that physical activity/exercise have a good effect on health.


Subject(s)
Exercise/psychology , Occupational Health , Women/psychology , Adult , Analysis of Variance , Cross-Sectional Studies , Female , Humans , Japan , Life Style , Male , Middle Aged , Models, Theoretical
6.
J Clin Pharmacol ; 42(12): 1374-9, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12463733

ABSTRACT

The clinical aspect of porphyria has been investigated, and it is well known that porphyrinogens such as estrogens and alcohol or other inducers of P450 isoenzymes exacerbate the porphyric state. However, there can be a delay in diagnosing porphyria and a difficulty in selecting safe medicine for it even today. A 21-year-old woman developed epilepsy, disturbance of mental state, and spastic tetraparesis during the convalescent period after acute viral encephalitis. She was diagnosed with porphyria after the fifth hospitalization. In the course of modifying her anticonvulsant regimen, the authors examined the 6beta-hydroxycortisol/cortisol ratio (6beta-OHF/F) in her urine, which can be the index of hepatic CYP3A4 activity, with electrospray ionization/mass spectrometry/mass spectrometry (ESI/MS/MS). Generalized and partial complex seizures, other neurological signs and symptoms, and laboratory data were improved after modification of her anticonvulsant regimen. This is the first report of evaluating the urinary 6beta-hydroxycortisol/cortisol ratio in a case of porphyria.


Subject(s)
Anticonvulsants/adverse effects , Cytochrome P-450 Enzyme System/biosynthesis , Hydrocortisone/analogs & derivatives , Hydrocortisone/urine , Microsomes/enzymology , Porphyrias/chemically induced , Adult , Cytochrome P-450 CYP3A , Cytochrome P-450 Enzyme System/genetics , Encephalitis, Herpes Simplex/complications , Enzyme Induction , Epilepsy/drug therapy , Epilepsy/etiology , Feces/chemistry , Female , Genotype , Humans , Mass Spectrometry , Porphyrias/diagnosis , Porphyrias/enzymology , Porphyrins/analysis , Porphyrins/urine , Quadriplegia/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...